Aggressive treatment tested for rare bone cancer that spreads

NCT ID NCT03011528

Completed Disease control Sponsor: Institut Curie Source: ClinicalTrials.gov ↗

Summary

This study tested an intensive chemotherapy approach for Ewing sarcoma that had already spread beyond the lungs at diagnosis. It involved 45 patients aged 2-50 who received strong induction chemotherapy followed by high-dose chemotherapy with stem cell support. The goal was to see if this aggressive treatment could improve survival for patients with this difficult-to-treat form of cancer.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Locations

Bordeaux Chu

Bordeaux, 33076, France
CHRU Montpellier - Hôpital A. de Villeneuve

Montpellier, 34295, France
CHU Grenoble Alpes

Grenoble, 38043, France
CHU Hôpital Sud

Rennes, 35056, France
Chr Felix Guyon

La Réunion, Saint Denis, 97400, France
LILLE Centre Oscar Lambret

Lille, 59000, France
LYON Centre Léon Bérard

Lyon, 69000, France
Marseille Chu

Marseille, 13000, France
NANCY Institut de Cancérologie de Lorraine

Vandœuvre-lès-Nancy, 54519, France
Nancy Chu

Vandœuvre-lès-Nancy, 54511, France
Nantes Chu

Nantes, 44000, France
PARIS Institut Curie

Paris, 75005, France
PARIS Trousseau

Paris, 75012, France
Strasbourg Chu

Strasbourg, 67098, France
TOULOUSE Institut Claudius Regaud

Toulouse, 31059, France
Toulouse Chu

Toulouse, 31059, France
VILLEJUIF Institut Gustave Roussy

Villejuif, 94805, France

Conditions

Explore the condition pages connected to this study.

EWING SARCOMA FAMILY OF TUMORS